UNFAVOURABLE INTERMEDIATE RISK PROSTATE CANCER

Clinical trials for UNFAVOURABLE INTERMEDIATE RISK PROSTATE CANCER explained in plain language.

Never miss a new study

Get alerted when new UNFAVOURABLE INTERMEDIATE RISK PROSTATE CANCER trials appear

Sign up with your email to follow new studies for UNFAVOURABLE INTERMEDIATE RISK PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Danish trial aims to boost cure rates and shorten prostate cancer treatment

Disease control Recruiting now

This large trial is testing two potential improvements to standard radiation therapy for men with intermediate or high-risk prostate cancer. It will see if delivering a higher, focused dose of radiation directly to visible tumors within the prostate improves cure rates. It will a…

Matched conditions: UNFAVOURABLE INTERMEDIATE RISK PROSTATE CANCER

Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Disease control

Last updated Mar 02, 2026 15:29 UTC

UNFAVOURABLE INTERMEDIATE RISK PROSTATE CANCER

Get alerted when new UNFAVOURABLE INTERMEDIATE RISK PROSTATE CANCER trials appear

Danish trial aims to boost cure rates and shorten prostate cancer treatment